Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome

Guillain-Barré syndrome (GBS) is an acute autoimmune polyradiculoneuropathy affecting 1–2 subjects per 100,000 every year worldwide. It causes, in its classic form, symmetric weakness in the proximal and distal limb muscles with common involvement of the cranial nerves, particularly facial weakness....

Descripción completa

Detalles Bibliográficos
Autor principal: Rajabally, Yusuf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159039/
https://www.ncbi.nlm.nih.gov/pubmed/35648286
http://dx.doi.org/10.1007/s13311-022-01253-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159039/
https://www.ncbi.nlm.nih.gov/pubmed/35648286
http://dx.doi.org/10.1007/s13311-022-01253-4

Ejemplares similares